Gut Colonization by Multidrug-resistant and Carbapenem-resistant Acinetobacter Baumannii in Neonates

Overview

Journal Eur J Clin Microbiol Infect Dis

Publisher Springer

Specialties Infectious Diseases
Microbiology

Date 2010 Aug 24

PMID 20730467

Citations 17

Authors

S Roy

R Viswanathan

A Singh

P Das

S Basu

Affiliations

Soon will be listed here.

Abstract

Infections caused by Acinetobacter baumannii are a threat to neonates because of its resistance to antimicrobials, including carbapenems. In 2007, A. baumannii emerged as an important aerobic Gram-negative bacillus (12.5%, 4/32) that caused sepsis in our unit. A. baumannii from the gut of the neonates was analyzed, as this could be indicative of the antibiotic resistance of the organisms. The study attempts to understand the gut colonization with multidrug-resistant A. baumannii among hospitalized neonates with special reference to carbapenem resistance. A. baumannii was found in the gut of 11% of babies. Interestingly, 60.7% (17/28) and 21.4% (6/28) of the isolates from the gut were multidrug-resistant and carbapenem-resistant, respectively. The number of multidrug-resistant and carbapenem-resistant isolates from blood cultures were 3/4 and 1/4, respectively. The study reports for the first time OXA-23 and OXA-58 carbapenemases in A. baumannii from India. Pulsed field gel electrophoresis (PFGE) patterns indicated that the strains were diverse and no epidemic clone existed. Though A. baumannii gut colonization could not be implicated as a risk factor for subsequent sepsis, the high rate of isolation of multidrug-resistant and carbapenem-resistant isolates indicates that these therapeutic options might be drastically reduced among neonates in the future.

Citing Articles

Amino acid competition shapes gut carriage.

Ren X, Clark R, Bansah D, Varner E, Tiffany C, Jaswal K bioRxiv. 2024; .

PMID: 39502362 PMC: 11537318. DOI: 10.1101/2024.10.19.619093.

Pathogen Distribution and Antimicrobial Resistance of Early Onset Sepsis in Very Premature Infants: A Real-World Study.

Ji H, Yu Y, Huang L, Kou Y, Liu X, Li S Infect Dis Ther. 2022; 11(5):1935-1947.

PMID: 35999433 PMC: 9617999. DOI: 10.1007/s40121-022-00688-8.

is Well Adapted to Withstand Intestinal Stressors and Modulate the Gut Epithelium.

Glover J, Browning B, Ticer T, Engevik A, Engevik M Front Physiol. 2022; 13:880024.

PMID: 35685287 PMC: 9170955. DOI: 10.3389/fphys.2022.880024.

Convergence of Biofilm Formation and Antibiotic Resistance in Infection.

Roy S, Chowdhury G, Mukhopadhyay A, Dutta S, Basu S Front Med (Lausanne). 2022; 9:793615.

PMID: 35402433 PMC: 8987773. DOI: 10.3389/fmed.2022.793615.

Overexpression of Efflux Pumps, Mutations in the Pumps' Regulators, Chromosomal Mutations, and AAC(6')-Ib-cr Are Associated With Fluoroquinolone Resistance in Diverse Sequence Types of Neonatal Septicaemic : A 7-Year Single Center Study.

Roy S, Chatterjee S, Bhattacharjee A, Chattopadhyay P, Saha B, Dutta S Front Microbiol. 2021; 12:602724.

PMID: 33776950 PMC: 7990795. DOI: 10.3389/fmicb.2021.602724.

References

Lee K, Chong Y, Shin H, Kim Y, Yong D, Yum J . Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect. 2001; 7(2):88-91. DOI: 10.1046/j.1469-0691.2001.00204.x. View

Corbella X, Montero A, Pujol M, Dominguez M, Ayats J, Argerich M . Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol. 2000; 38(11):4086-95. PMC: 87546. DOI: 10.1128/JCM.38.11.4086-4095.2000. View

Robenshtok E, Paul M, Leibovici L, Fraser A, Pitlik S, Ostfeld I . The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes. J Hosp Infect. 2006; 64(3):282-7. DOI: 10.1016/j.jhin.2006.06.025. View

Kluytmans-Vandenbergh M, Kluytmans J, Voss A . Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). Infection. 2005; 33(5-6):309-13. DOI: 10.1007/s15010-005-5079-z. View

Chiesa C, Panero A, Osborn J, Simonetti A, Pacifico L . Diagnosis of neonatal sepsis: a clinical and laboratory challenge. Clin Chem. 2004; 50(2):279-87. DOI: 10.1373/clinchem.2003.025171. View

Mostachio A, van der Heidjen I, Rossi F, Levin A, Costa S . Multiplex PCR for rapid detection of genes encoding oxacillinases and metallo-beta-lactamases in carbapenem-resistant Acinetobacter spp. J Med Microbiol. 2009; 58(Pt 11):1522-1524. DOI: 10.1099/jmm.0.011080-0. View

Poirel L, Nordmann P . Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006; 12(9):826-36. DOI: 10.1111/j.1469-0691.2006.01456.x. View

Zarrilli R, Giannouli M, Tomasone F, Triassi M, Tsakris A . Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities. J Infect Dev Ctries. 2009; 3(5):335-41. DOI: 10.3855/jidc.240. View

Jeon B, Jeong S, Bae I, Kwon S, Lee K, Young D . Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in korea. J Clin Microbiol. 2005; 43(5):2241-5. PMC: 1153754. DOI: 10.1128/JCM.43.5.2241-2245.2005. View

10.

Villegas M, Hartstein A . Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol. 2003; 24(4):284-95. DOI: 10.1086/502205. View

11.

Gupta V, Datta P, Chander J . Prevalence of metallo-beta lactamase (MBL) producing Pseudomonas spp. and Acinetobacter spp. in a tertiary care hospital in India. J Infect. 2005; 52(5):311-4. DOI: 10.1016/j.jinf.2005.08.013. View

12.

Lee K, Yum J, Yong D, Lee H, Kim H, Docquier J . Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother. 2005; 49(11):4485-91. PMC: 1280121. DOI: 10.1128/AAC.49.11.4485-4491.2005. View

13.

Touati A, Achour W, Cherif A, Hmida H, Afif F, Jabnoun S . Outbreak of Acinetobacter baumannii in a neonatal intensive care unit: antimicrobial susceptibility and genotyping analysis. Ann Epidemiol. 2009; 19(6):372-8. DOI: 10.1016/j.annepidem.2009.03.010. View

14.

Carvalho K, DAlincourt Carvalho-Assef A, Peirano G, dos Santos L, Pereira M, Asensi M . Dissemination of multidrug-resistant Acinetobacter baumannii genotypes carrying bla(OXA-23) collected from hospitals in Rio de Janeiro, Brazil. Int J Antimicrob Agents. 2009; 34(1):25-8. DOI: 10.1016/j.ijantimicag.2008.12.009. View

15.

Donskey C . Antibiotic regimens and intestinal colonization with antibiotic-resistant gram-negative bacilli. Clin Infect Dis. 2006; 43 Suppl 2:S62-9. DOI: 10.1086/504481. View

16.

Salyers A, Gupta A, Wang Y . Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol. 2004; 12(9):412-6. DOI: 10.1016/j.tim.2004.07.004. View

17.

Fournier P, Richet H . The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006; 42(5):692-9. DOI: 10.1086/500202. View

18.

Karthika R, Srinivasa Rao R, Sahoo S, Shashikala P, Kanungo R, Jayachandran S . Phenotypic and genotypic assays for detecting the prevalence of metallo-beta-lactamases in clinical isolates of Acinetobacter baumannii from a South Indian tertiary care hospital. J Med Microbiol. 2009; 58(Pt 4):430-435. DOI: 10.1099/jmm.0.002105-0. View

19.

Brown S, Amyes S . OXA (beta)-lactamases in Acinetobacter: the story so far. J Antimicrob Chemother. 2005; 57(1):1-3. DOI: 10.1093/jac/dki425. View

20.

Poirel L, Marque S, Heritier C, Segonds C, Chabanon G, Nordmann P . OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother. 2004; 49(1):202-8. PMC: 538857. DOI: 10.1128/AAC.49.1.202-208.2005. View